Ron Schaafsma
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 1
-
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 1
- PI3K/AKT/mTOR signaling in cancer 1
- Co-authors
- Harry C. Schouten (4 shared papers)Edo Vellenga (3 shared papers)Wim van Putten (1 shared paper)Gert J. Ossenkoppele (1 shared paper)Matthias Theobald (1 shared paper)Martin F. Fey (1 shared paper)Bob Löwenberg (1 shared paper)Jan J. Cornelissen (1 shared paper)
- Journals
- Blood (2 papers)Bone Marrow Transplantation (1 paper)European Journal of Cancer Care (1 paper)Data Archiving and Networked Services (DANS) (1 paper)Scandinavian Journal of Infectious Diseases (1 paper)
- Partner nations
- NetherlandsGermanySwitzerland
In The Last Decade
Ron Schaafsma
6 papers receiving 123 citations
Peers
Comparison fields: 5 of 25
- Hematology 93
- Geriatrics and Gerontology 9
- Genetics 12
- Public Health, Environmental and Occupational Health 25
- Transplantation 2
Countries citing papers authored by Ron Schaafsma
This map shows the geographic impact of Ron Schaafsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Schaafsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Schaafsma more than expected).
Fields of papers citing papers by Ron Schaafsma
This network shows the impact of papers produced by Ron Schaafsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Schaafsma. The network helps show where Ron Schaafsma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ron Schaafsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 86 | |
| 2 | 2019 | 15 | |
| 3 | 1988 | 9 | |
| 4 | 2004 | 8 | |
| 5 | 2010 | 6 | |
| 6 | PRETREATMENT WITH THALIDOMIDE AND BORTEZOMIB DOES NOT INFLUENCE RESPONSE TO LENALIDOMIDE IN RELAPSED MYELOMA. PRELIMINARY RESULTS FROM PATIENTS INCLUDED IN DUTCH COMPASSIONATE NEED PROGRAMME | 2008 | 1 |
| 7 | 2009 | 0 |
About Ron Schaafsma
Ron Schaafsma is a scholar working on Hematology, Molecular Biology, Oncology, Geriatrics and Gerontology and Epidemiology, having authored 7 papers that have together received 125 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (2 papers), Acute Myeloid Leukemia Research (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Neurological Complications and Syndromes (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Polyomavirus and related diseases (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Hematology (93 citations), Geriatrics and Gerontology (9 citations), Genetics (12 citations), Public Health, Environmental and Occupational Health (25 citations) and Transplantation (2 citations). Ron Schaafsma has collaborated with scholars based in Netherlands, Germany and Switzerland. Frequent co-authors include Harry C. Schouten, Edo Vellenga, Wim van Putten, Gert J. Ossenkoppele, Matthias Theobald, Martin F. Fey, Bob Löwenberg, Jan J. Cornelissen, Peter C. Huijgens and Urs Schanz. Their work appears in journals such as Blood, Bone Marrow Transplantation, European Journal of Cancer Care, Data Archiving and Networked Services (DANS) and Scandinavian Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.